Cargando…

Erchen Decoction Mitigates Lipid Metabolism Disorder by the Regulation of PPARγ and LPL Gene in a High-Fat Diet C57BL/6 Mice Model

Erchen decoction (ECD) is a common treatment prescribed in traditional Chinese medicine (TCM) clinics, which has remarkable efficacy in the treatment of obesity, fatty liver, hyperlipidemia, diabetes, and other diseases caused by phlegm. In this study, we investigated the effect that ECD had on the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Mengting, Shao, Yanfei, Gao, Bizhen, Chen, Jicheng, Zhang, Ping, Hu, Yujie, Ding, Shanshan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7085882/ https://www.ncbi.nlm.nih.gov/pubmed/32256662 http://dx.doi.org/10.1155/2020/9102475

Ejemplares similares

Erchen Decoction Prevents High-Fat Diet Induced Metabolic Disorders in C57BL/6 Mice
por: Gao, Bi-Zhen, et al.
Publicado: (2015)

Regulation of Fatty Acid Metabolism and Inhibition of Colorectal Cancer Progression by Erchen Decoction
por: Liao, Linghong, et al.
Publicado: (2023)

Investigating the effects and mechanisms of Erchen Decoction in the treatment of colorectal cancer by network pharmacology and experimental validation
por: Shao, Yanfei, et al.
Publicado: (2022)

Erchen Decoction Ameliorates the Metabolic Abnormalities of High-Fat Diet-Fed Rats
por: Cheng, Ya, et al.
Publicado: (2022)

Erchen Decoction Ameliorates Lipid Metabolism by the Regulation of the Protein CAV-1 and the Receptors VLDLR, LDLR, ABCA1, and SRB1 in a High-Fat Diet Rat Model
por: Ding, Shanshan, et al.
Publicado: (2018)

Retracted: Erchen Decoction Ameliorates the Metabolic Abnormalities of High-Fat Diet-Fed Rats
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Erchen decoction for hyperlipemia: Protocol for a systematic review and meta-analysis
por: Luo, Huan, et al.
Publicado: (2020)

Exploring the mechanism of Erchen decoction in the treatment of atherosclerosis based on network pharmacology and molecular docking
por: Li, Wenwen, et al.
Publicado: (2023)

Erchen decoction combined with Sanziyangqin decoction for chronic obstructive pulmonary disease: A protocol for systematic review and meta-analysis
por: Deng, Lu, et al.
Publicado: (2020)

The Effects of Erchen Decoction on Gut Microbiota and Lipid Metabolism Disorders in Zucker Diabetic Fatty Rats
por: Zhao, Tian, et al.
Publicado: (2021)

Erchen Decoction and Linguizhugan Decoction Ameliorate Hepatic Insulin Resistance by Inhibiting IRS-1Ser307 Phosphorylation In Vivo and In Vitro
por: Zhang, Huicun, et al.
Publicado: (2017)

Preserved glucose tolerance in high-fat-fed C57BL/6 mice transplanted with PPARγ(−/−), PPARδ(−/−), PPARγδ(−/−), or LXRαβ(−/−) bone marrow
por: Marathe, Chaitra, et al.
Publicado: (2009)

Herb-symptom analysis of Erchen decoction combined with Xiebai powder formula and its mechanism in the treatment of chronic obstructive pulmonary disease
por: Ye, Hua, et al.
Publicado: (2023)

Regional distribution of body fat in relation to DNA methylation within the LPL, ADIPOQ and PPARγ promoters in subcutaneous adipose tissue
por: Drogan, D, et al.
Publicado: (2015)

An ErChen and YinChen Decoction Ameliorates High-Fat-Induced Nonalcoholic Steatohepatitis in Rats by Regulating JNK1 Signaling Pathway
por: Xie, Tian-hong, et al.
Publicado: (2017)

Retracted: An ErChen and YinChen Decoction Ameliorates High-Fat-Induced Nonalcoholic Steatohepatitis in Rats by Regulating JNK1 Signaling Pathway
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2019)

Extract of Wax Gourd Peel Prevents High-Fat Diet-Induced Hyperlipidemia in C57BL/6 Mice via the Inhibition of the PPARγ Pathway
por: Gu, Ming, et al.
Publicado: (2013)

Rhein Reduces Fat Weight in db/db Mouse and Prevents Diet-Induced Obesity in C57Bl/6 Mouse through the Inhibition of PPARγ Signaling
por: Zhang, Yu, et al.
Publicado: (2012)

Citrus ichangensis Peel Extract Exhibits Anti-Metabolic Disorder Effects by the Inhibition of PPARγ and LXR Signaling in High-Fat Diet-Induced C57BL/6 Mouse
por: Ding, Xiaobo, et al.
Publicado: (2012)

Effects of Glycyrrhizic Acid on Peroxisome Proliferator-Activated Receptor Gamma (PPARγ), Lipoprotein Lipase (LPL), Serum Lipid and HOMA-IR in Rats
por: Yoke Yin, Chia, et al.
Publicado: (2010)

LPL, FNDC5 and PPARγ gene polymorphisms related to body composition parameters and lipid metabolic profile in adolescents from Southern Italy
por: Perrone, Benedetta, et al.
Publicado: (2022)

Intravenous injection of microvesicle-delivery miR-130b alleviates high-fat diet-induced obesity in C57BL/6 mice through translational repression of PPAR-γ
por: Pan, Shifeng, et al.
Publicado: (2015)

PPARγ Regulates Expression of Carbohydrate Sulfotransferase 11 (CHST11/C4ST1), a Regulator of LPL Cell Surface Binding
por: Tasdelen, Ismayil, et al.
Publicado: (2013)

Antrodan Alleviates High-Fat and High-Fructose Diet-Induced Fatty Liver Disease in C57BL/6 Mice Model via AMPK/Sirt1/SREBP-1c/PPARγ Pathway
por: Chyau, Charng-Cherng, et al.
Publicado: (2020)

Amelioration of Hypertriglyceridemia with Hypo-Alpha-Cholesterolemia in LPL Deficient Mice by Hematopoietic Cell-Derived LPL
por: Ding, Yinyuan, et al.
Publicado: (2011)

A Direct Comparison of Metabolic Responses to High-Fat Diet in C57BL/6J and C57BL/6NJ Mice
por: Fisher-Wellman, Kelsey H., et al.
Publicado: (2016)

Prenatal PPARα activation by clofibrate increases subcutaneous fat browning in male C57BL/6J mice fed a high-fat diet during adulthood
por: Chen, Szu-Han, et al.
Publicado: (2017)

Istradefylline Mitigates Age-Related Hearing Loss in C57BL/6J Mice
por: Shin, Min, et al.
Publicado: (2021)

Extracts of Pomelo Peels Prevent High-Fat Diet-Induced Metabolic Disorders in C57BL/6 Mice through Activating the PPARα and GLUT4 Pathway
por: Ding, Xiaobo, et al.
Publicado: (2013)

PPARγ and PPARα synergize to induce robust browning of white fat in vivo
por: Kroon, Tobias, et al.
Publicado: (2020)

Hepatocyte-specific Nrf2 deficiency mitigates high-fat diet-induced hepatic steatosis: Involvement of reduced PPARγ expression
por: Li, Lu, et al.
Publicado: (2019)

Differential Insulin Secretion of High-Fat Diet-Fed C57BL/6NN and C57BL/6NJ Mice: Implications of Mixed Genetic Background in Metabolic Studies
por: Attané, Camille, et al.
Publicado: (2016)

Effect of High-Fat Diet on Peripheral Neuropathy in C57BL/6 Mice
por: Xu, Lingling, et al.
Publicado: (2014)

Deciphering the active constituents of Dabushen decoction of ameliorating osteoarthritis via PPARγ preservation by targeting DNMT1
por: Qiu, Lu, et al.
Publicado: (2022)

Rare novel LPL mutations are associated with neonatal onset lipoprotein lipase (LPL) deficiency in two cases
por: Wu, Yun Qin, et al.
Publicado: (2021)

Responses to ethanol in C57BL/6 versus C57BL/6 × 129 hybrid mice
por: Lim, Jana P, et al.
Publicado: (2012)

Intervening TNF-α via PPARγ with Gegenqinlian Decoction in Experimental Nonalcoholic Fatty Liver Disease
por: Wang, Yun-liang, et al.
Publicado: (2015)

Sini Decoction Intervention on Atherosclerosis via PPARγ-LXRα-ABCA1 Pathway in Rabbits
por: Ju, Shicong, et al.
Publicado: (2018)

Erchen Plus Huiyanzhuyu Decoction Inhibits the Growth of Laryngeal Carcinoma in a Mouse Model of Phlegm-Coagulation-Blood-Stasis Syndrome via the STAT3/Cyclin D1 Pathway
por: Tan, Xi, et al.
Publicado: (2020)

C57BL/6J substrain differences in response to high-fat diet intervention
por: Siersbæk, Majken Storm, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_umh67oacrgr3pnfd2doefht8ot